Silence Therapeutics (SLN) Short Interest Ratio & Short Volume $4.80 -0.21 (-4.10%) As of 02:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Silence Therapeutics Short Interest DataSilence Therapeutics (SLN) has a short interest of 1.30 million shares. This marks a 15.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 341,820 shares to cover all short positions.Current Short Interest1,300,000 sharesPrevious Short Interest1,130,000 sharesChange Vs. Previous Month+15.04%Dollar Volume Sold Short$6.93 millionShort Interest Ratio2.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares29,790,000 sharesPercentage of Shares Shorted∞Today's Trading Volume80,909 sharesAverage Trading Volume341,820 sharesToday's Volume Vs. Average24% Short Selling Silence Therapeutics? Sign up to receive the latest short interest report for Silence Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSLN Short Interest Over TimeSLN Days to Cover Over TimeSLN Percentage of Float Shorted Over Time Silence Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20251,300,000 shares $6.93 million +15.0%N/A2.3 $5.33 1/15/20251,130,000 shares $6.01 million +14.7%N/A2.1 $5.32 12/31/2024985,000 shares $6.78 million +5.6%N/A2 $6.88 12/15/2024932,800 shares $6.02 million +32.8%N/A2 $6.45 11/30/2024702,300 shares $5.56 million +84.1%N/A1.7 $7.92 11/15/2024381,500 shares $4.85 million +8.0%N/A1.2 $12.70 10/31/2024353,300 shares $6.11 million +5.6%N/A2 $17.30 10/15/2024334,600 shares $6.12 million +7.2%N/A1.6 $18.29 9/30/2024312,200 shares $5.68 million +6.1%N/A1.4 $18.18 9/15/2024294,200 shares $5.50 million +15.6%N/A1.3 $18.69 Get the Latest News and Ratings for SLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024254,600 shares $4.86 million -27.4%N/A1.1 $19.09 8/15/2024350,500 shares $5.88 million -37.5%N/A1.7 $16.77 7/31/2024561,200 shares $11.50 million +0.1%N/A3.1 $20.50 7/15/2024560,700 shares $11.49 million -26.2%N/A3.6 $20.49 6/30/2024759,200 shares $14.42 million +15.3%N/A5.1 $19.00 6/15/2024658,400 shares $12.71 million +9.6%N/A5 $19.30 5/31/2024600,700 shares $12.61 million +3.5%N/A4 $20.99 5/15/2024580,600 shares $12.96 million +95.4%N/A3.1 $22.33 4/30/2024297,200 shares $6.50 million +104.0%N/A1.3 $21.86 4/15/2024145,700 shares $3.01 million -10.1%N/A0.6 $20.66 3/31/2024162,000 shares $3.50 million +74.8%N/A0.7 $21.60 3/15/202492,700 shares $2.12 million +100.7%N/A0.4 $22.84 2/29/202446,200 shares $1.18 million +31.6%N/A0.2 $25.47 2/15/202435,100 shares $768,339.00 -76.9%N/A0.2 $21.89 1/31/2024152,200 shares $3.43 million +6.7%N/A0.9 $22.51 1/15/2024142,700 shares $2.53 million +7.9%N/A1.3 $17.70 12/31/2023132,200 shares $2.30 million +1.0%N/A1.7 $17.37 12/15/2023130,900 shares $2.10 million -7.8%N/A2.3 $16.03 11/30/2023141,900 shares $1.83 million +1.0%N/A3.1 $12.87 11/15/2023140,500 shares $1.32 million +4.1%N/A2 $9.39 10/31/2023135,000 shares $904,500.00 -3.6%N/A2.2 $6.70 10/15/2023140,000 shares $1.09 million +3.1%N/A2.1 $7.76 9/30/2023135,800 shares $1.33 million +5.0%N/A2.1 $9.82 9/15/2023129,400 shares $1.29 million +7.9%N/A1.9 $9.95 8/31/2023119,900 shares $1.07 million -4.2%N/A1.3 $8.90 8/15/2023125,100 shares $800,640.00 +24.0%N/A2.2 $6.40 7/31/2023100,900 shares $601,364.00 +41.3%0.4%1.5 $5.96 7/15/202371,400 shares $414,120.00 +349.1%0.3%1 $5.80 6/30/202315,900 shares $87,450.00 +52.9%0.1%0.2 $5.50 6/15/202310,400 shares $63,752.00 +7.2%0.0%0.1 $6.13This Crypto Is Set to Explode in February (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 5/31/20239,700 shares $51,507.00 -56.7%0.0%0.1 $5.31 5/15/202322,400 shares $131,488.00 -36.7%0.1%0.3 $5.87 4/30/202335,400 shares $237,180.00 +91.4%0.1%0.6 $6.70 4/15/202318,500 shares $114,700.00 +30.3%0.1%0.3 $6.20 3/31/202314,200 shares $88,040.00 +11.8%0.1%0.4 $6.20 3/15/202312,700 shares $116,332.00 -12.4%0.0%0.3 $9.16 2/28/202314,500 shares $169,940.00 -17.1%0.1%0.3 $11.72 2/15/202317,500 shares $226,275.00 -22.2%0.1%0.5 $12.93 1/31/202322,500 shares $292,500.00 -2.6%0.1%0.7 $13.00 1/15/202323,100 shares $328,944.00 -24.3%0.1%0.7 $14.24 12/30/202230,500 shares $465,125.00 -23.9%0.1%0.9 $15.25 12/15/202240,100 shares $571,425.00 +28.9%0.1%1 $14.25 11/30/202231,100 shares $487,648.00 +16.5%0.1%0.7 $15.68 11/15/202226,700 shares $368,193.00 +24.2%0.1%0.6 $13.79 10/31/202221,500 shares $247,680.00 -30.7%0.1%0.4 $11.52 10/15/202231,000 shares $331,700.00 -8.3%0.1%0.5 $10.70 9/30/202233,800 shares $339,014.00 +39.7%0.1%0.6 $10.03 9/15/202224,200 shares $310,728.00 +50.3%0.1%0.4 $12.84 8/31/202216,100 shares $162,771.00 -13.9%0.1%0.3 $10.11 8/15/202218,700 shares $182,512.00 +24.7%0.1%0.4 $9.76 7/31/202215,000 shares $153,000.00 -20.6%0.1%0.4 $10.20 7/15/202218,900 shares $209,979.00 +13.2%0.1%0.6 $11.11 6/30/202216,700 shares $197,895.00 +3.7%0.1%0.6 $11.85 6/15/202216,100 shares $149,730.00 -8.0%0.1%0.7 $9.30 5/31/202217,500 shares $161,525.00 +133.3%0.1%0.9 $9.23 5/15/20227,500 shares $74,250.00 -90.6%0.0%0.3 $9.90 4/30/202279,700 shares $969,152.00 +0.3%0.3%3 $12.16 4/15/202279,500 shares $1.36 million -72.4%0.3%3.1 $17.10 3/31/2022287,500 shares $5.46 million +2,562.0%1.0%11.8 $19.00 3/15/202210,800 shares $178,200.00 +10.2%0.0%0.5 $16.50 2/28/20229,800 shares $179,340.00 -31.0%0.0%0.3 $18.30 2/15/202214,200 shares $313,252.00 +97.2%0.1%0.3 $22.06 1/31/20227,200 shares $151,200.00 +111.8%N/A0.2 $21.00 1/15/20223,400 shares $73,542.00 -40.4%N/A0.1 $21.63 12/31/20215,700 shares $136,173.00 -39.4%N/A0.1 $23.89 12/15/20219,400 shares $218,080.00 +261.5%N/A0.2 $23.20 11/30/20212,600 shares $61,100.00 +73.3%N/A0.1 $23.50 11/15/20211,500 shares $33,596.85 +150.0%N/A0.3 $22.40 10/29/2021600 shares $13,194.00 -53.9%N/A0.4 $21.99 10/15/20211,300 shares $28,366.00 +85.7%N/A0.9 $21.82 9/30/2021700 shares $14,427.00 -30.0%N/A0.4 $20.61 9/15/20211,000 shares $22,030.00 +25.0%N/A0.6 $22.03 8/31/2021800 shares $18,480.08 -69.2%N/A0.5 $23.10 8/13/20212,600 shares $65,468.00 -3.7%N/A2 $25.18 7/30/20212,700 shares $69,120.00 -20.6%N/A2.3 $25.60 7/15/20213,400 shares $86,700.00 +54.6%N/A2.4 $25.50 6/30/20212,200 shares $57,562.12 +37.5%N/A1.8 $26.16 6/15/20211,600 shares $45,300.16 -46.7%N/A1.8 $28.31 5/28/20213,000 shares $82,380.00 +66.7%N/A3.3 $27.46 5/14/20211,800 shares $45,702.00 +100.0%N/A2.6 $25.39This Crypto Is Set to Explode in February (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW 4/30/2021900 shares $23,481.00 +12.5%N/A1 $26.09 4/15/2021800 shares $18,504.00 +60.0%N/A0.8 $23.13 3/31/2021500 shares $11,475.00 -66.7%N/A0.5 $22.95 3/15/20211,500 shares $37,170.00 +25.0%N/A1.4 $24.78 2/26/20211,200 shares $31,680.00 No ChangeN/A1 $26.40 2/12/20211,200 shares $30,600.00 -55.6%N/A0.9 $25.50 1/29/20212,700 shares $68,850.00 +42.1%N/A2.5 $25.50 1/15/20211,900 shares $41,800.00 No ChangeN/A1.9 $22.00 SLN Short Interest - Frequently Asked Questions What is Silence Therapeutics' current short interest? Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 1,300,000 shares of SLN short. Learn More on Silence Therapeutics' current short interest. What is a good short interest ratio for Silence Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLN shares currently have a short interest ratio of 2.0. Learn More on Silence Therapeutics's short interest ratio. Which institutional investors are shorting Silence Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Silence Therapeutics: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Silence Therapeutics' short interest increasing or decreasing? Silence Therapeutics saw a increase in short interest in January. As of January 31st, there was short interest totaling 1,300,000 shares, an increase of 15.0% from the previous total of 1,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Silence Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Silence Therapeutics: Precigen, Inc. (11.70%), Stoke Therapeutics, Inc. (16.97%), Cullinan Therapeutics, Inc. (23.70%), Autolus Therapeutics plc (3.42%), Valneva SE (0.05%), Xeris Biopharma Holdings, Inc. (7.04%), Tectonic Therapeutic (13.84%), MeiraGTx Holdings plc (2.66%), Mineralys Therapeutics, Inc. (7.89%), Entrada Therapeutics, Inc. (7.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Silence Therapeutics stock? Short selling SLN is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. SLN shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Silence Therapeutics? A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SLN, which in turn drives the price of the stock up even further. How often is Silence Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLN, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Precigen Short Interest Stoke Therapeutics Short Interest Cullinan Therapeutics Short Interest Autolus Therapeutics Short Interest Valneva Short Interest Xeris Biopharma Short Interest Tectonic Therapeutic Short Interest MeiraGTx Short Interest Mineralys Therapeutics Short Interest Entrada Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SLN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLN Stock Alerts